Similarly, RUNX1 was determined as transcriptional target in KMT2A::AFF1, previously known as MLL::AF4, AML by Wilkinson et al. [49], suggesting that RUNX1 activity cooperates with KMT2Ar to promote AML development. This evidence concerns the gene RUNX1 and acute myeloid leukemia.